EMA started the evaluation of Richter's resubmitted marketing authorisation application for biosimilar pegfilgrastim
3/2/2018
Business related Regulatory Marketing authorization application filed Biotechnology PRODUCT - EFGRATIN API - PEGFILGRASTIM